E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/16/2013 in the Prospect News Bank Loan Daily and Prospect News Distressed Debt Daily.

S&P: Healogics loans B, CCC+

Standard & Poor's said it affirmed the B corporate credit rating on Healogics Inc.

The agency also said it assigned a B rating to Healogics' proposed $30 million first-lien revolving credit agreement and $290 million first-lien term loan with a recovery rating of 3, indicating 50% to 70% expected default recovery.

S&P also assigned a CCC+ rating on its proposed $110 million second-lien term loan with a recovery rating of 6, indicating 0 to 10% expected recovery in a default.

The outlook is stable.

The ratings reflect its highly leveraged financial risk profile, the agency said.

The company's weak business risk profile recognizes its good market position with a narrow operating focus, S&P said.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.